If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Barbara Rebesco is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Formularies Medicine & Life Sciences
Risk Management Medicine & Life Sciences
Italy Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Intensive Care Units Medicine & Life Sciences
Anti-Bacterial Agents Medicine & Life Sciences
Medication Errors Medicine & Life Sciences
Pharmacists Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2018

  • 158 Citations
  • 6 h-Index
  • 19 Article

Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in Italy

Damuzzo, V., Russi, A., Chiumente, M., Masini, C., Rebesco, B., Gregis, F., Nozza, S., Pigozzo, J., Chiarion-Sileni, V. & Palozzo, A. C., Jan 1 2018, (Accepted/In press) In : Journal of Oncology Pharmacy Practice.

Research output: Contribution to journalArticle

Italy
Pharmaceutical Preparations
Waste Management
Economics
ipilimumab

Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in Italy

Damuzzo, V., Russi, A., Chiumente, M., Masini, C., Rebesco, B., Gregis, F., Nozza, S., Pigozzo, J., Chiarion-Sileni, V. & Palozzo, A. C., Jan 1 2018, In : Journal of Oncology Pharmacy Practice. p. 1078155218755867

Research output: Contribution to journalArticle

Italy
Pharmaceutical Preparations
Waste Management
Economics
ipilimumab
3 Citations (Scopus)

Targeting the epidermal growth factor receptor can counteract the inhibition of natural killer cell function exerted by colorectal tumor-associated fibroblasts

Costa, D., Venè, R., Benelli, R., Romairone, E., Scabini, S., Catellani, S., Rebesco, B., Mastracci, L., Grillo, F., Minghelli, S., Loiacono, F., Zocchi, M. R. & Poggi, A., May 29 2018, In : Frontiers in Immunology. 9, MAY, 1150.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Natural Killer Cells
Colorectal Neoplasms
Mesenchymal Stromal Cells
Interleukin-2
13 Citations (Scopus)

High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients

Guolo, F., Minetto, P., Clavio, M., Miglino, M., Di Grazia, C., Ballerini, F., Pastori, G., Guardo, D., Colombo, N., Kunkl, A., Fugazza, G., Rebesco, B., Sessarego, M., Lemoli, R. M., Bacigalupo, A. & Gobbi, M., Aug 1 2016, In : American Journal of Hematology. 91, 8, p. 755-762 8 p.

Research output: Contribution to journalArticle

Idarubicin
Acute Promyelocytic Leukemia
Cytarabine
fludarabine
Homologous Transplantation